Valuation BeOne Medicines AG

Equities

Real-time Estimate Cboe BZX Other stock markets 04:36:12 14/03/26 am AEDT			5-day change	1st Jan Change
284.62 ^USD	-0.24%		-5.50%	-6.34%

28/02	RBC Lifts Price Target on BeOne Medicines to $425 From $417, Keeps Outperform Rating	MT
27/02	BeOne Medicines Returns to Profit in 2025 on 40% Revenue Jump	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	27,843	22,843	18,862	19,667	33,619	31,636	-	-
Change	-	-17.96%	-17.43%	4.27%	70.94%	-5.9%	-	-
Enterprise Value (EV) ¹	24,097	19,511	16,564	18,058	33,619	28,191	27,469	25,357
Change	-	-19.03%	-15.1%	9.02%	86.17%	-16.14%	-2.56%	-7.69%
P/E ratio	-17.8x	-11.3x	-21.3x	-30.2x	120x	51.5x	31x	23.9x
PBR	4.03x	5.17x	5.32x	5.84x	-	6.63x	5.09x	3.88x
PEG	-	-0.4x	0.4x	1.1x	-1x	0x	0.5x	0.8x
Capitalization / Revenue	23.7x	16.1x	7.67x	5.16x	6.29x	4.98x	4.28x	3.86x
EV / Revenue	20.5x	13.8x	6.74x	4.74x	6.29x	4.44x	3.72x	3.09x
EV / EBITDA	-17.3x	-11.3x	-14.8x	-45.6x	57.1x	29.9x	19.7x	12.8x
EV / EBIT	-16.7x	-10.9x	-13.7x	-31.8x	75.2x	37.7x	23.5x	15.5x
EV / FCF	-15.4x	-10.7x	-9.63x	-28.5x	-	48.8x	26.7x	17.1x
FCF Yield	-6.48%	-9.34%	-10.4%	-3.51%	-	2.05%	3.75%	5.84%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-15.23	-19.43	-8.45	-6.12	2.53	5.541	9.205	11.96
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,176	1,416	2,459	3,810	5,343	6,349	7,383	8,198
EBITDA ¹	-1,392	-1,723	-1,120	-396.4	588.8	942.9	1,394	1,976
EBIT ¹	-1,439	-1,790	-1,208	-568.2	447.1	747.1	1,171	1,639
Net income ¹	-1,413	-2,004	-881.7	-644.8	286.9	646.9	1,055	1,424
Net Debt ¹	-3,746	-3,332	-2,297	-1,609	-	-3,445	-4,167	-6,279
Reference price ²	270.93	219.94	180.36	184.71	303.81	285.30	285.30	285.30
Nbr of stocks (in thousands)	102,770	103,859	104,578	106,476	110,658	110,886	-	-
Announcement Date	25/2/22	27/2/23	26/2/24	27/2/25	26/2/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BEONE MEDICINES AG	51.49x	4.44x	29.9x	-.--%	31.64B
LONZA GROUP AG	33.31x	4.95x	16.6x	1.01%	43.38B
CELLTRION, INC.	54.39x	11.16x	31.03x	0.35%	30.26B
IQVIA HOLDINGS INC.	19.76x	2.34x	10.11x	-.--%	27.35B
REVOLUTION MEDICINES, INC.	-12.41x	321.65x	-10.47x	-.--%	18.84B
ASCENDIS PHARMA A/S	43.37x	8.27x	25.98x	-.--%	14.06B
MEDPACE HOLDINGS, INC.	25.96x	4.13x	18.76x	-.--%	12.6B
EUROFINS SCIENTIFIC SE	20.16x	1.87x	8.18x	1.22%	12.52B
IONIS PHARMACEUTICALS, INC.	-17.89x	13.94x	-19.43x	-.--%	11.95B
Average	24.24x	41.42x	12.30x	0.29%	22.51B
Weighted average by Cap.	29.62x	35.42x	15.58x	0.34%